← Back to Search

ATI-V Program for Preventing Adolescent Vaping

N/A
Waitlist Available
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
current 8th grade student of study school at start of school participation
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 28 months
Awards & highlights

Study Summary

This trial will test the effectiveness of a school-based intervention to reduce adolescent vaping. The intervention will train 8th-9th grade student peer leaders to deliver school-wide vaping prevention campaigns with ongoing adult mentoring.

Who is the study for?
This trial is for current 8th grade students in a participating school, regardless of race, color, national origin, sexual orientation, sex, gender identity, age or ability. Non-English speaking students cannot participate.Check my eligibility
What is being tested?
The study tests the 'Above the Influence-Vaping' (ATI-V) program where trained student peer leaders run anti-vaping campaigns with adult guidance to see if it can reduce vaping among adolescents.See study design
What are the potential side effects?
Since this intervention involves educational and social activities rather than medical treatments or drugs, there are no direct physical side effects associated with ATI-V.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently an 8th grader at the study school.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~28 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 28 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants with any past 30 day any vaping
Number of participants with any past 30 day nicotine vaping
Secondary outcome measures
Mean Electronic Vaping Product Attitudes
Score Electronic Vaping Product Harm
Total Number of Trusted Adults

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Immediate Above the Influence-Vaping InterventionExperimental Treatment1 Intervention
School receives Above the Influence-Vaping (ATI-V) prevention program training after baseline assessment. Training and intervention continue over two school years (approximately 18 months). Surveys at baseline, 8 months (end 8th grade), 20 mo (end 9th grade), 28 mo (mid-10th grade).
Group II: Delayed Above the Influence-Vaping InterventionActive Control1 Intervention
Surveys at baseline, 8 months (end 8th grade), 20 mo (end 9th grade), 28 mo (mid-10th grade). ATI-V prevention program training after 4th assessment - after 28 months.

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,465 Previous Clinical Trials
2,614,793 Total Patients Enrolled
9 Trials studying Vaping
1,232 Patients Enrolled for Vaping
Penn State UniversityOTHER
355 Previous Clinical Trials
121,917 Total Patients Enrolled
Claremont Graduate UniversityOTHER
9 Previous Clinical Trials
9,310 Total Patients Enrolled

Media Library

Above the Influence-Vaping (ATI-V) Clinical Trial Eligibility Overview. Trial Name: NCT04678245 — N/A
Vaping Research Study Groups: Delayed Above the Influence-Vaping Intervention, Immediate Above the Influence-Vaping Intervention
Vaping Clinical Trial 2023: Above the Influence-Vaping (ATI-V) Highlights & Side Effects. Trial Name: NCT04678245 — N/A
Above the Influence-Vaping (ATI-V) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04678245 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could I potentially partake in this research initiative?

"Candidates who wish to join this clinical trial must be between 12 and 18 years old, have a strong social network, and meet the 3840 participant quota."

Answered by AI

Is this trial accepting additional participants?

"According to clinicaltrials.gov, the medical trial in question has ceased recruitment efforts since its last update on May 9th 2022. Nevertheless, there are still 13 other studies actively seeking participants at this time."

Answered by AI

Does this trial cater to individuals over the age of 35?

"This trial is open to all children between 12-18 years of age."

Answered by AI
~725 spots leftby Feb 2025